Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Frederick Korpi

Orthopaedic Trauma North Canton, OH Doctor of Osteopathy

NPI 1477993947 CMS profile 2784560

7442 Frank Ave Nw, North Canton, OH 44720

Open in the dashboard

General payments

$13,172

164 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Frederick Korpi of North Canton, OH is reported in the CMS Open Payments database as having received $13,172 across 164 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 58th percentile of Orthopaedic Trauma profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $760 15
2024 General $1,638 26
2023 General $1,526 32
2022 General $1,288 21
2021 General $2,611 22
2020 General $1,157 13
2019 General $4,194 35

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Frederick Korpi
  • Orthopaedic Trauma median
  • Middle half of Orthopaedic Trauma
  • National median

In program year 2025, general payments to Frederick Korpi were reported at $760. Among 734 Orthopaedic Trauma profiles paid that year, the median was $1,227 and the middle half received between $259 and $7,433.

Show as a table
Year Frederick Korpi Orthopaedic Trauma median Middle half National median
2019 $4,194 $1,475 $264–$6,401 $163
2020 $1,157 $596 $120–$4,020 $114
2021 $2,611 $919 $171–$4,697 $132
2022 $1,288 $1,547 $272–$7,240 $149
2023 $1,526 $1,330 $247–$5,875 $160
2024 $1,638 $1,288 $277–$6,797 $164
2025 $760 $1,227 $259–$7,433 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $3,983 71 payments
  2. Arthrex, Inc. $3,504 13 payments
  3. SI-BONE, Inc. $1,652 17 payments
  4. Zimmer Biomet Holdings, Inc. $1,062 13 payments
  5. Rock Medical Orthopedics, Inc. $678 8 payments
  6. Smith+Nephew, Inc. $602 15 payments
  7. DePuy Synthes Sales Inc. $354 6 payments
  8. Aroa Biosurgery Incorporated $210 3 payments
  9. Kerecis Limited $195 2 payments
  10. Davol Inc. $152 1 payment
  11. Other $781 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $7,933 147 payments
  2. Education $2,926 5 payments
  3. Travel and Lodging $2,314 12 payments
Products named General payments · program years 2019–2025
  1. IFUSE IMPLANT $1,342 13 payments
  2. RibFix Blu $805 7 payments
  3. T2 ALPHA $566 13 payments
  4. PRO $428 9 payments
  5. MAKO $365 5 payments
  6. AXSOS $345 4 payments
  7. AUGMENT INJECTABLE $320 5 payments
  8. INSIGNIA $301 4 payments
  9. ASNIS $280 2 payments
  10. TRIATHLON $246 5 payments
  11. Other $6,982 119 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

157

Median for Orthopedic Surgery: 203

Drug cost

$919

Median for Orthopedic Surgery: $1,433

Branded share of claims

65%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 53 $511
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 49 $299
Tramadol Hcl Generic 20 $60
Meloxicam Generic 35 $49

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 87 billing codes

Paid by Medicare

$77,311

Medicare's payments for the services billed

Medicare patients

184

Average age 77

Services billed

1,079

119 women, 65 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 74%
Depression 46%
Diabetes 37%
Chronic kidney disease 36%
Ischemic heart disease 35%
Heart failure 33%
Atrial fibrillation 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

164 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Trauma in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record